Junko Takita

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 273 publications

An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation.

An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation.

Journal: Science immunology

Published: August 07, 2026

A genotype-first approach reveals the molecular basis of pyrin inflammasome activation.

A genotype-first approach reveals the molecular basis of pyrin inflammasome activation.

Journal: Science immunology

Published: August 07, 2026

Pediatric Case of Non-Islet Cell Tumor Hypoglycemia Driven by Hepatoblastoma: The Diagnostic Approach and Impact of Chemotherapy on Big IGF-II.

Pediatric Case of Non-Islet Cell Tumor Hypoglycemia Driven by Hepatoblastoma: The Diagnostic Approach and Impact of Chemotherapy on Big IGF-II.

Journal: Pediatric blood & cancer

Published: July 27, 2026

Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

Journal: bioRxiv : the preprint server for biology

Published: July 17, 2026

Mentorship to support career development among women physicians

Mentorship to support career development among women physicians

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Journal: Pediatric blood & cancer

Published: May 07, 2026

Pediatric T-Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission.

Pediatric T-Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission.

Journal: Pediatric blood & cancer

Published: April 30, 2026

Protocol for live cell barcoding and immunophenotyping of human hematological malignancies using cytometry by time of flight.

Protocol for live cell barcoding and immunophenotyping of human hematological malignancies using cytometry by time of flight.

Journal: STAR protocols

Published: March 26, 2026

Anti-Integrin αvβ6 Autoantibodies as Diagnostic and Monitoring Biomarkers for Pediatric-Onset Primary Sclerosing Cholangitis.

Anti-Integrin αvβ6 Autoantibodies as Diagnostic and Monitoring Biomarkers for Pediatric-Onset Primary Sclerosing Cholangitis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 11, 2026

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Journal: NPJ precision oncology

Published: February 14, 2026

Emergency ABO-Incompatible Living-Donor Liver Transplantation for Acute Liver Failure due to Intentional Iron Poisoning.

Emergency ABO-Incompatible Living-Donor Liver Transplantation for Acute Liver Failure due to Intentional Iron Poisoning.

Journal: Pediatric transplantation

Published: February 03, 2026

A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

Journal: Cancer science

Published: January 30, 2026

Showing 1-12 of 273

Last Updated: 09/26/2026